Citigroup Maintains Neutral on Cardinal Health, Lowers Price Target to $107
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Daniel Grosslight maintains a Neutral rating on Cardinal Health (NYSE:CAH) but lowers the price target from $115 to $107.
July 19, 2024 | 7:33 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Citigroup analyst Daniel Grosslight maintains a Neutral rating on Cardinal Health but lowers the price target from $115 to $107.
The lowered price target from $115 to $107 by Citigroup suggests a less optimistic outlook for Cardinal Health, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100